1. Home
  2. HOOK vs NYC Comparison

HOOK vs NYC Comparison

Compare HOOK & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HOOK
  • NYC
  • Stock Information
  • Founded
  • HOOK 2011
  • NYC 2013
  • Country
  • HOOK United States
  • NYC United States
  • Employees
  • HOOK N/A
  • NYC N/A
  • Industry
  • HOOK Biotechnology: Pharmaceutical Preparations
  • NYC Real Estate
  • Sector
  • HOOK Health Care
  • NYC Finance
  • Exchange
  • HOOK Nasdaq
  • NYC Nasdaq
  • Market Cap
  • HOOK 24.5M
  • NYC 23.8M
  • IPO Year
  • HOOK 2019
  • NYC N/A
  • Fundamental
  • Price
  • HOOK $1.99
  • NYC $8.99
  • Analyst Decision
  • HOOK Buy
  • NYC
  • Analyst Count
  • HOOK 4
  • NYC 0
  • Target Price
  • HOOK $10.67
  • NYC N/A
  • AVG Volume (30 Days)
  • HOOK 266.1K
  • NYC 6.4K
  • Earning Date
  • HOOK 03-21-2025
  • NYC 11-12-2024
  • Dividend Yield
  • HOOK N/A
  • NYC N/A
  • EPS Growth
  • HOOK N/A
  • NYC N/A
  • EPS
  • HOOK N/A
  • NYC N/A
  • Revenue
  • HOOK $49,999,000.00
  • NYC $62,060,000.00
  • Revenue This Year
  • HOOK $148.80
  • NYC N/A
  • Revenue Next Year
  • HOOK N/A
  • NYC $3.18
  • P/E Ratio
  • HOOK N/A
  • NYC N/A
  • Revenue Growth
  • HOOK 143.30
  • NYC N/A
  • 52 Week Low
  • HOOK $1.72
  • NYC $5.46
  • 52 Week High
  • HOOK $10.50
  • NYC $10.91
  • Technical
  • Relative Strength Index (RSI)
  • HOOK 45.83
  • NYC 53.11
  • Support Level
  • HOOK $1.80
  • NYC $8.50
  • Resistance Level
  • HOOK $1.99
  • NYC $9.24
  • Average True Range (ATR)
  • HOOK 0.24
  • NYC 0.50
  • MACD
  • HOOK 0.05
  • NYC 0.02
  • Stochastic Oscillator
  • HOOK 25.35
  • NYC 65.79

About HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

About NYC American Strategic Investment Co.

American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.

Share on Social Networks: